August 1, 2018
- Patent Certifications and Suitability Petitions (updated)
- Safety Risks Associated with Certain Bulk Drug Substances Nominated for Use in Compounding (updated)
- First Generic Drug Approvals (updated)
- Pulmonary-Allergy Advisory Committee Charter (updated)
- Cardiovascular and Renal Drugs Advisory Committee Charter (updated)
- Pharmacy Compounding Advisory Committee Charter (updated)
- AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam for Injection 3.375 grams per vial, Due to Presence of Particulates Identified as Glass and Silicone Material
- FDA Drug Shortages
- Morphine Sulfate Injection, USP (Updated - Currently in Shortage)
- Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
- Potassium Chloride Injection (New - Currently in Shortage)
.png)
No hay comentarios:
Publicar un comentario